Skip to main content
Clinical Trials/JPRN-UMIN000001893
JPRN-UMIN000001893
Unknown
Phase 3

Randomized controlled trial of the combination of exercise therapy and BCAA supplementation for chronic liver diseases - Randomized controlled trial of the combination of exercise therapy and BCAA supplementation for chronic liver diseases (RCEBL)

Tohoku University0 sites40 target enrollmentMay 1, 2009

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
chronic liver disease
Sponsor
Tohoku University
Enrollment
40
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2009
End Date
March 1, 2011
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Patients with poor oral intake 2\. Pasthistory of allergic reaction to the ingredients of Aminofeel 3\.Patients with risky varices for upper GI bleeding 4\. Patients of diabetes with poor control of the concentration of blood sugar 5\. Patients of hypertention with poor control of blood pressure 6\. Patients with history of severe cardiovascular diseases 7\.Patients with clinical manifestation of hepatic encephalopathy 8\.Patients inappropriate for participating to this study decided by the attending physicians.

Outcomes

Primary Outcomes

Not specified

Similar Trials